By reducing the immune-suppressive and increasing the immune-competent subpopulations of cells in the TME, the β3-AR blockade proved the hypothesis that β3-ARs might play a role in the promotion of immune tolerance of melanoma. Here, ADRB3 is linked to melanoma.